Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded Access Program of CNT-01 in Idiopathic Triglyceride Deposit Cardiomyovasculopathy
jRCT2051220160Completed
- Sponsor
- TOA EIYO
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tricaprin in idiopathic triglyceride deposit cardiomyovasculopathy (I-TGCV), sponsored by TOA EIYO. Primary endpoints: Adverse events and Adverse drug reactions. Started Feb 2023; status: completed.
02
Drugs
tricaprin
03
Conditions
idiopathic triglyceride deposit cardiomyovasculopathy (I-TGCV)
Beyond the preview
Go deeper on jRCT2051220160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051220160.